Access TOC
Download Data
December 2024
The safety lancets market was estimated at US$ 2.1 billion in 2023 and is projected to grow to US$ 6.32 billion by 2034, rising at a compound annual growth rate (CAGR) of 10.54% from 2024 to 2034. The increasing demand for point-of-care diagnostics, the need to prevent needlestick injuries, and technological advancements drive the market.
Unlock Infinite Advantages: Subscribe to Annual Membership
Lancets are small, sharp needles used to puncture the skin to withdraw a minuscule quantity of blood. However, standard lancets carry the risk of needlestick injuries. Safety lancets are a safer alternative to standard lancets as they contain retractable needles, thereby preventing accidental pricks and reducing the risk of infection. Safety lancets are more specific and personalized to every patient type, as they can puncture and penetrate to a predetermined depth during sample collection. These lancets are commonly used to withdraw blood during blood glucose monitoring. They are also used in various tests such as lipid profiles, HbA1C, and blood typing.
The rising prevalence of chronic disorders like diabetes and cholesterol increases the demand for safety needles. The rising needlestick injuries from standard lancets promote the use of safety lancets. Additionally, technological advancements and the latest innovations in safety lancets boost market growth.
In April 2024, HTL-Strefa announced that it received expanded US FDA approval for its Droplet Micron 34G x 3.5 mm pen needle from prescription-only to over-the-counter use. Droplet Micron will also be used for subcutaneous injection of drugs, such as GLP-1 analogs, apart from insulin.
The sales of B.Braun in 2023 were around 8,755 EUR million, a 3% increase from last year, out of which the gross profit was reported to be 3,322.4 EUR million. Also, B.Braun spent 484.6 EUR million in research & development in 2023.
The development of blood self-sampling devices or lancing devices increases the demand and use of safety lancets. These devices automatically collect blood samples from the skin, offering a standardized and safe approach to obtaining blood samples. This benefits children, the geriatric population, and adults having a fear of piercing their skin. Hence, the advent of self-sampling devices increases patient adherence. These devices enable interoperability and interface with the current total lab automation. Additionally, they are affordable, sustainable, and of high quality. The devices either collect blood from the upper arm or prick the finger. Blood sampling can maintain laboratory testing for patients who live far away from the hospital. The increasing investments in microfluidics and demand for safe, latest innovations and painless withdrawal of blood potentiate the market growth.
Patients from numerous developing countries are unaware of the safety lancets for withdrawing capillary blood. Most of the people use conventional lancets as they are a cheaper alternative and easily available. Safety lancets are also not preferred due to pain, fear and anxiety. This hampers the market growth.
North America held the largest share of the safety lancets market in 2023. The rising prevalence of diabetes and other disorders, advanced healthcare infrastructure, increasing investments, and technological advancements drive the market. In 2022, around 38.4 million people in the US and around 5.7 million people in Canada were suffering from both type 1 and 2 diabetes. According to the Centers for Disease Control and Prevention, more than half of the US citizens are suffering from cholesterol. The Occupational Safety and Health Administration promotes the use of safety lancets among healthcare workers who perform finger-prick blood sampling in the workplace to prevent needlestick injuries. The Canadian Government governs the use of glucometers, test strips, and lancets for regular monitoring of blood glucose levels with an aim to prevent serious diabetes complications and long-term hospitalizations. The market is also driven by increasing awareness, and the presence of key players augment market growth.
Asia-Pacific is projected to host the fastest-growing safety lancets market in the coming years. The rising geriatric population, increasing prevalence of diabetes and other chronic illnesses, increasing investments, and demand for point-of-care diagnostics drive the market. The rising prevalence of chronic disorders potentiates regular testing for these disorders, thereby increasing the demand for safety lancets. China accounts for more than half of the familial hypercholesterolemia cases in the world. In the Asia-Pacific region, familial hypercholesterolemia accounts for almost 15 million cases. Several organizations conduct training sessions to increase awareness of the use of safety lancets in the region.
By type, the pressure-activated safety lancet segment held the largest share in the safety lancets market in 2023. A pressure-activated safety lancet is a device that withdraws blood by placing it on the finger and applying very little pressure, enabling the needle to prick the skin and retract it. It does not contain a button to aid the needle to come out. It is widely preferred due to its simplicity, sterility, and pain-masking ability. It increases patient adherence as it offers safety and comfort for the patient.
The side button safety lancet segment is projected to expand rapidly in the safety lancet market in the coming years. A side button safety lancet consists of a button that automatically retracts and locks, protecting against accidental needlestick injuries. Its spring-loaded action helps ensure a swift, gentle action with controlled penetration.
By end-use, the hospitals & clinics segment registered its dominance over the global market in 2023. Hospitals & clinics have sufficient facilities and tools for point-of-care diagnosis. Numerous patients prefer hospitals & clinics for testing purposes as they are governed by stringent regulations and provide high-quality testing services. Additionally, hospitals & clinics have suitable facilities for disposing of the safety lancets. In hospitals & clinics, patients can undergo blood testing for several other disorders, but at-home care testing is not available.
The home diagnostics segment is expected to grow at the fastest rate in the market during the forecast period. Home diagnostics are the most preferred option for geriatric patients. The availability of at-home care testing devices for blood glucose monitoring and HbA1C levels potentiates the market growth.
By Type
By End-Use
By Region
December 2024
December 2024
December 2024
December 2024
Annual Access, Limitless Research! Unlock all market research reports with our annual subscription. Stay on top of market trends and crucial insights year-round!
2500+
Client Queries in 20235000+
Insights Published60+
Consulting Projects Per Year40+
Analysts